IPHA

Innate Pharma
IPHA

9 hedge funds and large institutions have $735K invested in Innate Pharma in 2023 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 0 increasing their positions, 4 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

more funds holding

Funds holding: →

more first-time investments, than exits

New positions opened: | Existing positions closed:

less ownership

Funds ownership: →

less capital invested

Capital invested by funds: $ → $

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 4

Holders
9
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$133K
2
+$41.7K
3
+$643

Top Sellers

1
-$447K
2
-$133K
3
-$39.1K
4
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$37.8K
5
Morgan Stanley
Morgan Stanley
New York
-$5.14K
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$257K
2
$155K
3
$145K
4
$133K
5
$41.7K
6
$1.54K
7
$1K
8
$643
9
$449
10
–
11
–